Figure 1From: Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients Patient flow. Dose-titration and parallel-group phases include patients in the safety set. LC: lanthanum carbonate; R: randomization.Back to article page